Details for Patent: 5,681,814
✉ Email this page to a colleague
Summary for Patent: 5,681,814
| Title: | Formulated IGF-I Composition |
| Abstract: | A formulation for IGF-I is disclosed that is useful in treating hyperglycemic disorders and, in combination with growth hormone, in enhancing growth of a mammal. Also disclosed is a process for preparing a formulation of growth hormone and IGF-I from the IGF-I formulation. The IGF-I formulation comprises about 2-20 mg/ml of IGF-I, about 2-50 mg/ml of an osmolyte, about 1-15 mg/ml of a stabilizer, and a buffered solution at about pH 5-5.5, optionally with a surfactant. |
| Inventor(s): | Clark; Ross G. (Pacifica, CA), Yeung; Douglas A. (Fremont, CA), Oeswein; James Q. (Moss Beach, CA) |
| Assignee: | Genentech, Inc. (South San Francisco, CA) |
| Application Number: | 08/071,819 |
|
Patent Claim Types: see list of patent claims | Composition; Formulation; Use; |
Drugs Protected by US Patent 5,681,814
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 5,681,814
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | 141799 | ⤷ Try a Trial | |||
| Austria | 143267 | ⤷ Try a Trial | |||
| Australia | 5451294 | ⤷ Try a Trial | |||
| Australia | 675996 | ⤷ Try a Trial | |||
| Brazil | 1100122 | ⤷ Try a Trial | |||
| Canada | 2083159 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
